Pausing Treatment for Pregnancy
Young women who have had hormone receptor-positive breast cancer can safely suspend endocrine therapy to try to have a child.
Young women who have had hormone receptor-positive breast cancer can safely suspend endocrine therapy to try to have a child.
New oral hormonal therapy offers alternative to injections for some women with metastatic disease.
Accumulating research shows lifelong stressors degrade health and increase cancer risk, but exercise might help counteract the impact of stress.
A small study finds no cancer recurrences after two years in patients who skipped breast surgery following a complete response to chemotherapy—but experts say the research is in its very early stages.
The FDA has approved the oral SERD elacestrant to treat certain patients with estrogen receptor-positive breast cancer. The U.S. Food and Drug Administration (FDA) has approved elacestrant (Orserdu) for the treatment of men and...
Many women underestimate dense breast effect on cancer risk, and FDA approves targeted therapy for colorectal cancer.
The new AKT inhibitor doubled progression-free survival when added to treatment with Faslodex.
Study finds pausing endocrine therapy is safe for early-stage breast cancer patients eager to expand their families.
Black breast cancer patients had worse outcomes in a recent study, even when cancer features aligned with white patients.
Clinical trial results are changing care for people with metastatic breast cancer that expresses low levels of HER2 protein.